Pretreatment prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer: Perfusion metrics of dynamic contrast enhanced MRI.

about

Pretreatment prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer: Perfusion metrics of dynamic contrast enhanced MRI.

Item

http://www.wikidata.org/entity/Q55426221

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Pretreatment prediction of pat ...... dynamic contrast enhanced MRI.

@en

Pretreatment prediction of pat ...... dynamic contrast enhanced MRI.

@nl

type

Item

label

Pretreatment prediction of pat ...... dynamic contrast enhanced MRI.

@en

Pretreatment prediction of pat ...... dynamic contrast enhanced MRI.

@nl

prefLabel

Pretreatment prediction of pat ...... dynamic contrast enhanced MRI.

@en

Pretreatment prediction of pat ...... dynamic contrast enhanced MRI.

@nl

P1476

Pretreatment prediction of pat ...... dynamic contrast enhanced MRI.

@en

P2093

Jeongmin Lee

http://www.w3.org/2001/XMLSchema#string

Sung Hun Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging.

Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.

Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment.

Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma

Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer.

Background Parenchymal Enhancement on Preoperative Magnetic Resonance Imaging: Association With Recurrence-Free Survival in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.

Background parenchymal enhancement in the contralateral normal breast of patients undergoing neoadjuvant chemotherapy measured by DCE-MRI.

Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer.

Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery.

Surgical considerations in locally advanced breast cancer patients receiving neoadjuvant chemotherapy.

P304

9490

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-018-27764-9

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Bong Joo Kang

P577

2018-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29934524

http://www.w3.org/2001/XMLSchema#string

P932

6014994

http://www.w3.org/2001/XMLSchema#string